Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine

06:52 EDT 28 Jun 2013 | ChinaBio Today

Shanghai BravoBio Co. has in-licensed China rights to RotaShield®, an oral rotavirus vaccine that was developed by the International Medica Foundation of the US. The vaccine is the first that can be given to newborns, and it requires only two dos...

Original Article: Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine

NEXT ARTICLE

More From BioPortfolio on "Shanghai BravoBio Licenses China Rights to Rotavirus Vaccine"

Search BioPortfolio:
Advertisement

Relevant Topics

Vaccine
Latest News Clinical Trials Research Drugs Reports Corporate
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one...

Pediatrics
Latest News Clinical Trials Research Drugs Reports Corporate
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With...

Advertisement

Searches Linking to this Story